Atlas Trials

Anesthetic Efficacy of 2% Mepivacaine Versus 4% Articaine

Clinical trial NCT03725579 · UNKNOWN

Trial details

NCT number
NCT03725579
Sponsor
Cairo University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Symptomatic Irreversible Pulpitis
Start date
2018-09-15
Primary completion
2018-12-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.